World's First Automated Insulin-Delivery Device Approved in the U.S.

The U.S. Food and Drug Administration today approved
Medtronic’s MiniMed 670G hybrid closed looped system, the
first FDA-approved device that is intended to automatically
monitor glucose (sugar) and provide appropriate basal
insulin doses in people 14 years of age and older with type 1
diabetes.

The human pancreas naturally supplies a low, continuous
rate of insulin, known as basal or background insulin. In
patients with diabetes, the body’s ability to produce or
respond to insulin is impaired.

Click here to read full news at the FDA official site.

Please share with friends on Facebook and whatsapp to help in health stabilization.